TRIM5α-independent anti-human immunodeficiency virus type 1 activity mediated by cyclophilin A in Old World monkey cells

Virology

Volumn 375, Issue 2, 2008, Pages 514-520

  Nakayama, Emi E ^a   Shingai, Yasuhiro ^a   Kono, Ken ^a   Shioda, Tatsuo ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Cyclophilin A; HIV 1; Old World monkey; TRIM5

Indexed keywords

CYCLOPHILIN A; CYCLOSPORIN A; TRIPARTITE MOTIF PROTEIN 5; PROTEIN; TRIM5(ALPHA) PROTEIN, RHESUS MONKEY;

ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; VIRUS REPLICATION; ANIMAL; CELL LINE; CERCOPITHECIDAE; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

CERCOPITHECIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

ANIMALS; CELL LINE; CERCOPITHECIDAE; CYCLOPHILIN A; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, NATURAL; PROTEINS; VIRULENCE; VIRUS REPLICATION;

EID: 43249092769     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.02.028     Document Type: Article

References (49)

1. Adachi A., Gendelman H.E., Koeing S., Folks T., Willey R., Rabson A., and Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 (1986) 284-291
2. Berthoux L., Sebastian S., Sokolskaja E., and Luban J. Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA. J. Virol. 78 (2004) 11739-11750
3. Berthoux L., Sebastian S., Sokolskaja E., and Luban J. Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14849-14853
4. Braaten D., Aberham C., Franke E.K., Yin L., Phares W., and Luban J. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A. J. Virol. 70 (1996) 5170-5176
5. Braaten D., Franke E.K., and Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70 (1996) 3551-3560
6. Braaten D., and Luban J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J. 20 (2001) 1300-1309
7. Bukovsky A.A., Weimann A., Accola M.A., and Gottlinger H.G. Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10943-10948
8. Diaz-Griffero F., Vandegraaff N., Li Y., McGee-Estrada K., Stremlau M., Welikala S., Si Z., Engelman A., and Sodroski J. Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology 351 (2006) 404-419
9. Diaz-Griffero F., Kar A., Lee M., Stremlau M., Poeschla E., and Sodroski J. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology 369 (2007) 400-410
10. Dorfman T., Weimann A., Borsetti A., Walsh C.T., and Gottlinger H.G. Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions. J. Virol. 71 (1997) 7110-7113
11. Franke E.K., and Luban J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 222 (1996) 279-282
12. Franke E.K., Yuan H.E., and Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372 (1994) 359-362
13. Gamble T.R., Vajdos F.F., Yoo S., Worthylake D.K., Houseweart M., Sundquist W.I., and Hill C.P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87 (1996) 1285-1294
14. Hatziioannou T., Perez-Caballero D., Yang A., Cowan S., and Bieniasz P.D. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10774-10779
15. Javanbakht H., Diaz-Griffero F., Yuan W., Yeung D.F., Li X., Song B., and Sodroski J. The ability of multimerized cyclophilin A to restrict retrovirus infection. Virology 306 (2007) 19-29
16. Kamada K., Igarashi T., Martin M.A., Khamsri B., Hatcho K., Yamashita T., Fujita M., Uchiyama T., and Adachi A. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16959-16964
17. Keckesova Z., Ylinen L.M., and Towers G.J. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10780-10785
18. Keckesova Z., Ylinen L.M., and Towers G.J. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to old world monkey but not human TRIM5{alpha} antiviral activity. J. Virol. 80 (2006) 4683-4690
19. Kootstra N.A., Munk C., Tonnu N., Landau N.R., and Verma I.M. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1298-1303
20. Li M., Wang H., Li F., Fisher W.E., Chen C., and Yao Q. Effect of cyclophilin A on gene expression in human pancreatic cancer cells. Am. J. Surg. 190 (2005) 739-745
21. Luban J. Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J. Virol. 81 (2007) 1054-1061
22. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., and Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73 (1993) 1067-1078
23. Mische C.C., Javanbakht H., Song B., Diaz-Griffero F., Stremlau M., Strack B., Si Z., and Sodroski J. Retroviral restriction factor TRIM5alpha is a trimer. J. Virol. 79 (2005) 14446-14450
24. Miyoshi H., Blomer U., Takahashi M., Gage F.H., and Verma I.M. Development of a self-inactivating lentivirus vector. J. Virol. 72 (1998) 8150-8157
25. Miyoshi H., Takahashi M., Gage F.H., and Verma I.M. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10319-10323
26. Nakatsu Y., Takeda M., Kidokoro M., Kohara M., and Yanagi Y. Rescue system for measles virus from cloned cDNA driven by vaccinia virus Lister vaccine strain. J. Virol. Methods 137 (2006) 152-155
27. Nakayama E.E., Miyoshi H., Nagai Y., and Shioda T. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J. Virol. 79 (2005) 8870-8877
28. Nakayama E.E., Tanaka Y., Nagai Y., Iwamoto A., and Shioda T. A CCR2-V64I polymorphism affects stability of CCR2A isoform. Aids 18 (2004) 729-738
29. Nisole S., Lynch C., Stoye J.P., and Yap M.W. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13324-13328
30. Perez-Caballero D., Hatziioannou T., Yang A., Cowan S., and Bieniasz P.D. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J. Virol. 79 (2005) 8969-8978
31. Perron M.J., Stremlau M., Song B., Ulm W., Mulligan R.C., and Sodroski J. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11827-11832
32. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., and Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 20 (2001) 2140-2151
33. Rosenwirth B., Billich A., Datema R., Donatsch P., Hammerschmid F., Harrison R., Hiestand P., Jaksche H., Mayer P., Peichl P., et al. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrob. Agents Chemother. 38 (1994) 1763-1772
34. Sawyer S.L., Wu L.I., Emerman M., and Malik H.S. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2832-2837
35. Sayah D.M., Sokolskaja E., Berthoux L., and Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430 (2004) 569-573
36. Shibata R., Miura T., Hayami M., Ogawa K., Sakai H., Kiyomasu T., Ishimoto A., and Adachi A. Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). J. Virol. 64 (1990) 742-747
37. Sokolskaja E., Sayah D.M., and Luban J. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J. Virol. 78 (2004) 12800-12808
38. Sokolskaja E., Berthoux L., and Luban J. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells. J. Virol. 80 (2006) 2855-2862
39. Song H., Nakayama E.E., Yokoyama M., Sato H., Levy J.A., and Shioda T. A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. J. Virol. 81 (2007) 7280-7285
40. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427 (2004) 848-853
41. Stremlau M., Perron M., Welikala S., and Sodroski J. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J. Virol. 79 (2005) 3139-3145
42. Stremlau M., Song B., Javanbakht H., Perron M., and Sodroski J. Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1. Virology 351 (2006) 112-120
43. Takeda M., Ohno S., Seki F., Hashimoto K., Miyajima N., Takeuchi K., and Yanagi Y. Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells. Virus Res. 108 (2005) 161-165
44. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., and Gottlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature 372 (1994) 363-365
45. Towers G.J. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 4 (2007) 40
46. Towers G.J., Hatziioannou T., Cowan S., Goff S.P., Luban J., and Bieniasz P.D. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat. Med. 9 (2003) 1138-1143
47. Yang H., Li M., Chai H., Yan S., Lin P., Lumsden A.B., Yao Q., and Chen C. Effects of cyclophilin A on cell proliferation and gene expressions in human vascular smooth muscle cells and endothelial cells. J. Surg. Res. 123 (2005) 312-319
48. Yap M.W., Nisole S., Lynch C., and Stoye J.P. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10786-10791
49. Yap M.W., Nisole S., and Stoye J.P. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr. Biol. 15 (2005) 73-78